• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

(+)-顺式-3,5-二甲基-2-(3-吡啶基)噻唑烷-4-酮盐酸盐(SM-12502)作为人肝微粒体中细胞色素P450 2A6的新型底物。

(+)-cis-3,5-dimethyl-2-(3-pyridyl) thiazolidin-4-one hydrochloride (SM-12502) as a novel substrate for cytochrome P450 2A6 in human liver microsomes.

作者信息

Nunoya K, Yokoi Y, Kimura K, Kodama T, Funayama M, Inoue K, Nagashima K, Funae Y, Shimada N, Green C, Kamataki T

机构信息

Division of Drug Metabolism, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.

出版信息

J Pharmacol Exp Ther. 1996 May;277(2):768-74.

PMID:8627557
Abstract

(+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride (SM-12502) was oxidized by human liver microsomes to produce the S-oxide as a sole metabolite. Indirect evidence suggested that the S-oxidation was catalyzed by cytochrome P450 (CYP). Eadie-Hofstee plots showed biphasic pattern, suggesting that at least two enzymes were involved in the S-oxidation in human liver microsomes. Kinetic parameters of the S-oxidase with high-affinity showed Km and Vmax values of 20.9 +/- 4.4 microM and 0.111 +/- 0.051 nmol/min/mg microsomal protein, respectively. The S-oxidase activity was inhibited by coumarin and anti-CYP2A antibody. Among the contents of forms of CYP 20 samples of human liver microsomes, the content of CYP2A6 correlated with S-oxidase activity measured with 50 microM SM-12502 (r = .808, P < .0005). A close correlation (r = .908, P < .0001) was observed between activities of SM-12502 S-oxidase and coumarin 7-hydroxylase. Microsomes from genetically engineered human B-lymphoblastoid cells expressing CYP2A6 metabolized SM-12502 to the S-oxide efficiently. The results indicate that CYP2A6 isozyme is a major form of CYP responsible for the S-oxidation of SM-12502 in human liver microsomes. Thus, SM-12502 will be a useful tool in further research to analyze a human genetic polymorphism of CYP2A6.

摘要

(+)-顺式-3,5-二甲基-2-(3-吡啶基)噻唑烷-4-酮盐酸盐(SM-12502)被人肝微粒体氧化,生成唯一的代谢产物S-氧化物。间接证据表明,S-氧化反应由细胞色素P450(CYP)催化。伊迪-霍夫斯泰因图呈现双相模式,表明人肝微粒体中的S-氧化反应至少涉及两种酶。高亲和力S-氧化酶的动力学参数显示,Km和Vmax值分别为20.9±4.4微摩尔和0.111±0.051纳摩尔/分钟/毫克微粒体蛋白。香豆素和抗CYP2A抗体可抑制S-氧化酶活性。在人肝微粒体20个样本的CYP形式含量中,CYP2A6的含量与用50微摩尔SM-12502测得的S-氧化酶活性相关(r = 0.808,P < 0.0005)。观察到SM-12502 S-氧化酶活性与香豆素7-羟化酶活性之间存在密切相关性(r = 0.908,P < 0.0001)。表达CYP2A6的基因工程人B淋巴母细胞的微粒体可有效地将SM-12502代谢为S-氧化物。结果表明,CYP2A6同工酶是负责在人肝微粒体中对SM-12502进行S-氧化的主要CYP形式。因此,SM-12502将成为进一步研究分析CYP2A6人类基因多态性的有用工具。

相似文献

1
(+)-cis-3,5-dimethyl-2-(3-pyridyl) thiazolidin-4-one hydrochloride (SM-12502) as a novel substrate for cytochrome P450 2A6 in human liver microsomes.(+)-顺式-3,5-二甲基-2-(3-吡啶基)噻唑烷-4-酮盐酸盐(SM-12502)作为人肝微粒体中细胞色素P450 2A6的新型底物。
J Pharmacol Exp Ther. 1996 May;277(2):768-74.
2
A new deleted allele in the human cytochrome P450 2A6 (CYP2A6) gene found in individuals showing poor metabolic capacity to coumarin and (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride (SM-12502).在对香豆素和(+)-顺式-3,5-二甲基-2-(3-吡啶基)噻唑烷-4-酮盐酸盐(SM-12502)代谢能力较差的个体中发现的人类细胞色素P450 2A6(CYP2A6)基因的一个新的缺失等位基因。
Pharmacogenetics. 1998 Jun;8(3):239-49. doi: 10.1097/00008571-199806000-00006.
3
Characterization of CYP2A6 involved in 3'-hydroxylation of cotinine in human liver microsomes.人肝微粒体中参与可替宁3'-羟基化反应的CYP2A6的特性研究。
J Pharmacol Exp Ther. 1996 May;277(2):1010-5.
4
Human cytochrome P450 isozymes in metabolism and health effects of gasoline ethers.人类细胞色素P450同工酶在汽油醚的代谢及健康影响中的作用
Res Rep Health Eff Inst. 2001 May(102):7-27; discussion 95-109.
5
Roles of CYP2A6 and CYP2B6 in nicotine C-oxidation by human liver microsomes.CYP2A6和CYP2B6在人肝微粒体对尼古丁C-氧化中的作用。
Arch Toxicol. 1999 Mar;73(2):65-70. doi: 10.1007/s002040050588.
6
Metabolism of methyl tert-butyl ether and other gasoline ethers by human liver microsomes and heterologously expressed human cytochromes P450: identification of CYP2A6 as a major catalyst.人肝微粒体和异源表达的人细胞色素P450对甲基叔丁基醚及其他汽油醚的代谢:确定CYP2A6为主要催化剂
Toxicol Appl Pharmacol. 1999 Oct 1;160(1):43-8. doi: 10.1006/taap.1999.8750.
7
Bioactivation of tegafur to 5-fluorouracil is catalyzed by cytochrome P-450 2A6 in human liver microsomes in vitro.在体外人肝微粒体中,替加氟向5-氟尿嘧啶的生物活化由细胞色素P-450 2A6催化。
Clin Cancer Res. 2000 Nov;6(11):4409-15.
8
Roles of human CYP2A6 and rat CYP2B1 in the oxidation of (+)-fenchol by liver microsomes.人细胞色素P450 2A6和大鼠细胞色素P450 2B1在肝微粒体对(+)-小茴香醇氧化中的作用。
Xenobiotica. 2007 Sep;37(9):943-53. doi: 10.1080/00498250601167083.
9
Role of human cytochrome P4502A6 in C-oxidation of nicotine.人类细胞色素P4502A6在尼古丁C氧化中的作用。
Drug Metab Dispos. 1996 Nov;24(11):1212-7.
10
CYP2A6 AND CYP2B6 are involved in nornicotine formation from nicotine in humans: interindividual differences in these contributions.细胞色素P450 2A6(CYP2A6)和细胞色素P450 2B6(CYP2B6)参与人体中尼古丁向去甲烟碱的转化:这些作用存在个体差异。
Drug Metab Dispos. 2005 Dec;33(12):1811-8. doi: 10.1124/dmd.105.006254. Epub 2005 Aug 31.

引用本文的文献

1
Variation in CYP2A6 Activity and Personalized Medicine.CYP2A6活性的变异与个性化医疗
J Pers Med. 2017 Dec 1;7(4):18. doi: 10.3390/jpm7040018.
2
PharmGKB summary: very important pharmacogene information for cytochrome P-450, family 2, subfamily A, polypeptide 6.药物基因组知识库总结:细胞色素P-450 2A亚家族6多肽的非常重要的药物基因信息。
Pharmacogenet Genomics. 2012 Sep;22(9):695-708. doi: 10.1097/FPC.0b013e3283540217.
3
A novel CYP2A6 allele, CYP2A6*23, impairs enzyme function in vitro and in vivo and decreases smoking in a population of Black-African descent.
一种新的CYP2A6等位基因CYP2A6*23,在体外和体内均会损害酶的功能,并减少非洲裔黑人人群的吸烟量。
Pharmacogenet Genomics. 2008 Jan;18(1):67-75. doi: 10.1097/FPC.0b013e3282f3606e.
4
Identification of novel CYP2A6*1B variants: the CYP2A6*1B allele is associated with faster in vivo nicotine metabolism.新型CYP2A6*1B变体的鉴定:CYP2A6*1B等位基因与体内尼古丁代谢加快有关。
Clin Pharmacol Ther. 2008 Jan;83(1):115-21. doi: 10.1038/sj.clpt.6100246. Epub 2007 May 23.
5
Genetic polymorphism of drug metabolizing enzymes: new mutations in CYP2D6 and CYP2A6 genes in Japanese.药物代谢酶的基因多态性:日本人CYP2D6和CYP2A6基因中的新突变
Pharm Res. 1998 Apr;15(4):517-24. doi: 10.1023/a:1011913407147.